Skip to main content

Table 1 Baseline characteristics in non-diabetic patients with STEMI based on MAGE levels

From: Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention

 

MAGE (mmol/L)

p

≤3.26

>3.26

n

170

86

 

Patient demographics

 Age (years)

61 (39–77)

64 (36–79)

<0.001

 Males

99 (58.2)

56 (65.1)

0.344

 BMI (kg/m2)

26.6 (20.3–33.1)

26.7 (22.5–41.9)

0.727

Medical history

 Prior MI

16 (9.4)

14 (16.3)

0.148

 Prior PCI

26 (15.3)

14 (16.3)

0.857

 Prior CABG

10 (5.9)

7 (8.1)

0.596

Risk factors

 Hypertension

112 (65.9)

61 (70.9)

0.480

 Hyperlipidemia

87 (51.2)

54 (62.8)

0.085

 Current smoking

82 (48.2)

47 (54.7)

0.356

 LVEF (%)

55.47 ± 9.94

50.27 ± 9.89

<0.001

 eGFR (mL/min/1.73 m2)

71.67 ± 29.05

62.55 ± 17.76

0.008

 TC (mmol/L)

4.60 ± 0.95

4.67 ± 1.02

0.588

 TG (mmol/L)

1.82 ± 1.39

1.90 ± 0.73

0.591

 ABG (mmol/L)

7.01 ± 1.68

7.91 ± 2.20

<0.001

 MAGE (mmol/L)

2.17 ± 0.73

4.28 ± 1.06

<0.001

 HbA1c (%)

4.71 ± 0.90

5.70 ± 1.50

<0.001

Angiographic data

 Culprit vessel, LAD

68 (40.0)

38 (44.2)

0.591

 Multi-vessel CAD

78 (45.9)

53 (61.6)

0.024

 TIMI grade 3 before PCI

46 (27.1)

15 (17.4)

0.120

 TIMI grade 3 after PCI

163 (95.9)

78 (90.7)

0.156

 Stents

1.51 ± 0.87

1.79 ± 1.09

0.027

  1. Data are mean ± SD and number (%)
  2. STEMI ST elevated myocardial infarction, MAGE the mean amplitude of glycemic excursions, BMI body mass index, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, LVEF left ventricular ejection fraction, eGFR estimated glomerular filtration rate, TC total cholesterol, TG triglyceride, ABG admission blood glucose, HbA 1c glycated hemoglobin, LAD left anterior descending artery, CAD coronary artery disease
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us